Login
$CATX
$1.25 +$0.06 (5.04%) Close

$CATX 3 SEC Filings

Filed On Filing
05 Sep 2025 Form 3: Sendek Joel, Chief Financial Officer

No securities owned

05 Sep 2025 Form 3: Martinez Maria E, Director

No securities owned

07 Jan 2025 Form 3: Graham Juan, Chief Financial Officer

Holds 2,021 shares of Common Stock

01 Feb 2024 Form 3: Lantheus Alpha Therapy, Llc, 10% owner and 1 other

Holds 56,342,355 shares of Common Stock

02 Jun 2023 Form 3: Henson Heidi, Director

No securities owned

17 Mar 2023 Form 3: Williamson Robert F Iii, Director

No securities owned

13 Feb 2023 Form 3: Morich Frank, Director
13 Feb 2023 Form 3: Puhlmann Markus, Chief Medical Officer

Holds 500,000 shares of Common Stock

13 Feb 2023 Form 3: Spoor Johan M., Director

Holds 37,572 shares of Common Stock

20 Sep 2019 Form 3: Cline Krista, Dir. of Operations, Secretary

Holds 1,033 shares of Common Stock

04 Sep 2019 Form 3: Hunt Jonathan Robert, Chief Financial Officer
19 Jun 2018 Form 3: Woods Lori A, Director
28 Jul 2017 Form 3: Austin Mark John, Controller/Prin Fin&Acct Offic
29 Jun 2017 Form 3: Streeter Jennifer, VP of Human Resources

Holds 5,440 shares of Common Stock

26 Jan 2017 Form 3: Branson Matthew, Principal Fin & Acct Officer
23 Jun 2016 Form 3: Krachon Michael, VP of Sales & Marketing
19 Jan 2016 Form 3: Hoffmann Alan, Director

No securities owned

22 Jun 2015 Form 3: McCormick Michael W, Director

No securities owned

22 Jan 2014 Form 3: Vitale Philip J, Director

No securities owned

18 Oct 2010 Form 3: Cavanagh William, Vice President

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support